Urology – Bladder cancer immunotherapy regimens have been updated and added to the CRUK website. A new form for Nivolumab has been added. Revalidation of the remaining regimen specific consent…
The Education and Training Subcommittee are in the process of updating the eLearning content on the BOPA website. As part of this update, we are looking for an experienced pharmacist…
The next episode of Let’s Talk About SACT is Let’s talk about Diffuse Large B Cell Lymphoma (DLBCL). In this episode we are joined by Chris Salmen. We discuss what…
The UK ECRC August 2024 newsletter is now available UK ECRC Newsletter – August 2024 – BOPA
The BOPA SACT Verification Passport team continue to work behind the scenes to update and review content to optimise the use of this e-learning and training platform. We appreciate all…
The BOPA 2024 Executive Committee Election is now open for voting. Thank you to all of our nominees this year – we really appreciate your nominations for the Executive Committee.…
The next episode of Let’s Talk About SACT is Let’s talk about Hyperthermic Intraperitoneal Chemotherapy. In this episode we are joined by Apini Patel. We discuss what hyperthermic intraperitoneal chemotherapy…
We are delighted to share a BOPA EDI publication is now available on line. Equity, diversity, and inclusion in oncology pharmacy practice: Everyone’s business – Pascale Dettwiller, Suhani Ghiya, Jurga…
Dr Shereen Nabhani-Gebara is BOPA’s Vice Chair and she has been awarded Professor of Oncology at Kingston University. Shereen’s Research is dedicated to improving healthcare outcomes using technology and addressing…
BOPA is looking for new Executive Committee members who are dedicated to furthering the association’s aims and who are willing, and able, to spend time helping run the organisation. Those…
BOPA is delighted to announce the publication of TRANScribing: Clinical considerations for safe and inclusive prescribing for transgender and non-binary patients in collaboration with OUTpatients. It is estimated that one…
As an exciting addition to the 2024 conference, we invite you all to participate in one of our interactive sessions on the Sunday morning. We have a lineup of…
